Iron-Based MRI dye could replace risky gadolinium for vein scans
Diagnosis
Recruiting now
This study tests a new MRI contrast agent called ferumoxytol, made from iron nanoparticles, to see if it can safely and effectively image veins in people with vein diseases. Current dyes can be risky for patients with kidney problems, but ferumoxytol may be safer and last longer …
Phase: PHASE2 • Sponsor: Min Zhou • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC